Table 2. Effect of CP-1, CP-2, and CP-6 on Dexamethasone-induced hyperlipidemia in rats.
| Group | Serum total Cholesterol(mg/dl) | Triglycerides (mg/dl) |
HDL-C (mg/dl) | LDL-C (mg/dl) | VLDL-C (mg/dl) | Atherogenic Index |
|---|---|---|---|---|---|---|
| G1 | 59.42±2.24 | 101.2±3.41 | 24.54±1.17 | 12.81±2.41 | 20.24±1.32 | 1.42±0.25 |
| G2 | 104.4±6.92*** | 285.4±19.55*** | 18.22±2.31 *** | 22.41±1.54*** | 60.48±2.65*** | 4.73±0.54 *** |
| G3 | 92.11±4.65 †† | 205.8±4.74 †† | 18.94±1.64 ns | 19.74±1.96 ††† | 41.16±2.22 ††† | 3.86±0.18 ††† |
| G4 | 75.66±6.22 ††† | 185.4±7.22 ††† | 20.24±1.64 ††† | 16.78±0.32 ††† | 37.08±2.98 ††† | 2.74±0.15 ††† |
| G5 | 93.48±7.14 †† | 190.6±6.24 †† | 19.54±1.74 † | 19.94±1.84 ††† | 38.12±2.45 ††† | 3.78±0.23 ††† |
| G6 | 79.56±4.87 ††† | 168.7±8.47 ††† | 21.84±1.61 ††† | 17.45±1.25 ††† | 33.74±1.96 ††† | 2.64±0.22 ††† |
| G7 | 84.28±3.76 †† | 178.24±5.33 †† | 20.87±2.21 ††† | 17.65±1.98 ††† | 35.64±2.78 ††† | 3.04±0.35 ††† |
| G8 | 61.19±2.24 ††† | 113.5±4.21 ††† | 22.56±2.84 ††† | 12.44±1.56 ††† | 22.74±1.57 ††† | 1.71±0.12 ††† |
| G9 | 61.24±3.54 ††† | 134.7±9.22 ††† | 23.44±1.84 ††† | 14.97±1.22 ††† | 26.94±1.68 ††† | 1.61±0.14 ††† |
G1=Normal control, G2=Pathogenic control, G3=CP-1 -25 mg/kg p.o, G4=CP-1 -50 mg/kg p.o, G5=CP-2 -25 mg/kg p.o, G6=CP-2 -50 mg/kg p.o, G7=CP-6 -25 mg/kg p.o, G8=CP-6 -50 mg/kg p.o, G9=Atorvastatin -10 mg/kg p.o.
The values are expressed as Mean±SEM, (n=8).* Pathogenic control vs. Normal control (*** p<0.001), † Treatments vs. Pathogenic control
(† p<0.05, †† p<0.01, ††† p<0.001).